Literature DB >> 28511390

Expression of Angiogenic Factors in Psoriasis Vulgaris.

Lakshna Sankar1, Dhanalakshmi Arumugam2, Sudha Boj3, Priyanka Pradeep1.   

Abstract

INTRODUCTION: Psoriasis is a chronic inflammatory skin disease characterized by epidermal hyperproliferation, abnormal differentiation and inflammatory infiltration in the dermis. The dermal microvascular expansion associated with abnormal orientation and dilatation of capillaries in the biopsies of the psoriatic skin suggest that the disease is dependent on angiogenesis. AIM: To analyze and compare the immunohistochemical expression of angiogenic factors - Vascular Endothelial Growth Factor (VEGF), von Willebrand Factor (vWF) and CD 34 in skin biopsies of psoriasis cases with control skin samples; and to correlate the expression of angiogenic factors with Psoriasis Area and Severity Clinical Index (PASI SCORE).
MATERIALS AND METHODS: This was a prospective case control study conducted over a period of 15 months. Thirty-two psoriasis cases and thirty control skin samples were included in the study. Skin biopsy specimen was taken from clinically diagnosed psoriasis cases who did not receive any treatment. The diagnosis of psoriasis vulgaris was confirmed after microscopic examination. Immunohistochemical expression for VEGF, vWF and CD 34 was studied.
RESULTS: VEGF expression in epidermis was significantly higher in cases when compared to control skin (p <0.01). CD 34 expression was significantly upregulated in cases when compared to controls (p<0.01). Von Willebrand factor expression was weak in both the cases and the controls. Significant correlation between the expression of VEGF and PASI score (r=0.944; p<0.01), and expression of CD 34 and PASI score was observed (r=0.942; p<0.01).
CONCLUSION: In the present study, significant overexpression of VEGF and CD 34 was noted in cases when compared to controls. The keratinocytes in the psoriatic skin lesions were recognized as a source of pro-angiogenic cytokines namely the VEGF and other growth factors which promotes angiogenesis in psoriatic plaque. Angiogenesis plays an important role in genesis and development of psoriasis vulgaris. Therefore, development of targeted anti-angiogenic therapy might be beneficial for this chronic disabling dermatological disease.

Entities:  

Keywords:  CD 34; Epidermis; PASI score

Year:  2017        PMID: 28511390      PMCID: PMC5427316          DOI: 10.7860/JCDR/2017/23039.9525

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  40 in total

Review 1.  Angiogenesis in psoriasis.

Authors:  D Creamer; D Sullivan; R Bicknell; J Barker
Journal:  Angiogenesis       Date:  2002       Impact factor: 9.596

2.  Psoriasis in India: prevalence and pattern.

Authors:  Sunil Dogra; Savita Yadav
Journal:  Indian J Dermatol Venereol Leprol       Date:  2010 Nov-Dec       Impact factor: 2.545

3.  Active and inactive edges of psoriatic plaques: identification by tracing and investigation by laser--Doppler flowmetry and immunocytochemical techniques.

Authors:  S M Hull; M Goodfield; E J Wood; W J Cunliffe
Journal:  J Invest Dermatol       Date:  1989-06       Impact factor: 8.551

Review 4.  Angiogenesis drives psoriasis pathogenesis.

Authors:  Regina Heidenreich; Martin Röcken; Kamran Ghoreschi
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

5.  Localization of endothelial proliferation and microvascular expansion in active plaque psoriasis.

Authors:  D Creamer; M H Allen; A Sousa; R Poston; J N Barker
Journal:  Br J Dermatol       Date:  1997-06       Impact factor: 9.302

6.  Quantification of microvascular changes in the skin in patients with psoriasis.

Authors:  S P Barton; M S Abdullah; R Marks
Journal:  Br J Dermatol       Date:  1992-06       Impact factor: 9.302

7.  Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis.

Authors:  Helen S Young; Angela M Summers; Ian R Read; David A Fairhurst; Darren J Plant; Emanuela Campalani; Catherine H Smith; Jonathan N W N Barker; Michael J Detmar; Paul E C Brenchley; Christopher E M Griffiths
Journal:  J Invest Dermatol       Date:  2006-02       Impact factor: 8.551

8.  Ultrastructure of the capillary loops in the dermal papillae of psoriasis.

Authors:  I M Braverman; A Yen
Journal:  J Invest Dermatol       Date:  1977-01       Impact factor: 8.551

9.  Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis.

Authors:  Peter M Elias; Jack Arbiser; Barbara E Brown; Heidemarie Rossiter; Mao-Qiang Man; Francesca Cerimele; Debra Crumrine; Roshan Gunathilake; Eung Ho Choi; Yoshikazu Uchida; Erwin Tschachler; Kenneth R Feingold
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

10.  Differential expression of the angiogenesis growth factors in psoriasis vulgaris.

Authors:  Siaw-Cheok Liew; Esha Das-Gupta; Srikumar Chakravarthi; Shew-Fung Wong; Nagarajah Lee; Najeeb Safdar; Adawiyah Jamil
Journal:  BMC Res Notes       Date:  2012-07-03
View more
  9 in total

1.  Perfusion measured by laser speckle contrast imaging as a predictor for expansion of psoriasis lesions.

Authors:  Mirjam J Schaap; Ata Chizari; Tom Knop; Hans M M Groenewoud; Piet E J van Erp; Elke M G J de Jong; Wiendelt Steenbergen; Marieke M B Seyger
Journal:  Skin Res Technol       Date:  2021-10-07       Impact factor: 2.240

2.  A Preliminary Study of the Effect of Semaphorin 3A and Acitretin on the Proliferation, Migration, and Apoptosis of HaCaT Cells.

Authors:  Wei Ding; Yi Cao; Fengling Xing; Maocan Tao; Hongyang Fu; Hongbin Luo; Xiaohong Yang
Journal:  Indian J Dermatol       Date:  2019 May-Jun       Impact factor: 1.494

3.  Network Pharmacology-Based Analysis on the Mechanism of Action of Ephedrae Herba-Cinnamomi Ramulus Couplet Medicines in the Treatment for Psoriasis.

Authors:  Shun Guo; Jin-Yong Zhou; Cheng Tan; Le Shi; Yue Shi; Jianxin Shi
Journal:  Med Sci Monit       Date:  2021-01-29

4.  Aging in psoriasis vulgaris: female patients are epigenetically older than healthy controls.

Authors:  Pavel Borsky; Marcela Chmelarova; Zdenek Fiala; Kvetoslava Hamakova; Vladimir Palicka; Jan Krejsek; Ctirad Andrys; Jan Kremlacek; Vit Rehacek; Martin Beranek; Andrea Malkova; Tereza Svadlakova; Drahomira Holmannova; Lenka Borska
Journal:  Immun Ageing       Date:  2021-03-03       Impact factor: 6.400

5.  Novel nanoemulsion gel containing triple natural bio-actives combination of curcumin, thymoquinone, and resveratrol improves psoriasis therapy: in vitro and in vivo studies.

Authors:  Karishma Khatoon; Asgar Ali; Fahan J Ahmad; Zubair Hafeez; M Moshahid A Rizvi; Sohail Akhter; Sarwar Beg
Journal:  Drug Deliv Transl Res       Date:  2020-09-23       Impact factor: 4.617

6.  Association of Benzodiazepine Receptor Agonist Use With Changes in Psoriasis Severity in Adult Population: A Population-Based Study.

Authors:  Ke-Ting Pan; I-Hsun Li; Hui-Han Kao; Yi-Hsien Chen; Pei-Xun Zhong; Li-Ting Kao
Journal:  Front Pharmacol       Date:  2021-07-05       Impact factor: 5.810

7.  CD137: A Member of the TNFR Family - in Psoriasis Skin Lesions in Comparison with Normal Skin Specimens.

Authors:  Parvin Rajabi Dehnavi; Seyyed Mehdi Eftekhari; Azadeh Kadkhodaei; Amirhosein Kefayat
Journal:  Iran J Pathol       Date:  2020-12-20

Review 8.  Antivascular endothelial growth factor-A therapy: a novel personalized treatment approach for psoriasis.

Authors:  Andrea Luengas-Martinez; Ralf Paus; Helen S Young
Journal:  Br J Dermatol       Date:  2022-03-17       Impact factor: 11.113

9.  The association of serum vascular endothelial growth factor levels and psoriasis vulgaris: A protocol for systematic review and meta-analysis.

Authors:  Juan Gong; Hua Yang; Dongwei Qi; Xueyong Tang
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.